Malaysia aims to produce its first locally manufactured human vaccine by 2028, a strategic move designed to reduce the country’s reliance on imported medical supplies. Science, Technology and Innovation Minister Chang Lih Kang confirmed that the initiative is currently underway, with the local pharmaceutical company Pharmaniaga Bhd involved in the development process.
The vaccines produced under this program will be used to treat several serious health conditions, including pneumonia, meningitis, sepsis, and various blood infections. By establishing domestic production capabilities, the government intends to strengthen national health security and decrease dependency on foreign vaccine manufacturers.
In-depth summary · AI, neutral